Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | BAY2287411 |
Synonyms | |
Therapy Description |
BAY2287411 is a radioimmunoconjugate consisting of the radionuclide thorium-227 linked to the mesothelin (MSLN) targeting antibody BAY 86-1903 (anetumab), which induces DNA damage and cell cycle arrest, potentially resulting in increased apoptosis, reduced cell viability, and inhibition of tumor growth (PMID: 31064781). |